We are very pleased to welcome Heidi Moawad, MD as the first ever Editor in Chief of our journal, beginning February 1, 2019.
Presenting our year in review, a collection by experts in their respective fields of brain injury, MS, concussion, epilepsy, migraine, and more.
You’ll want to get to bed early on Thursday, because you’ll have a very full week ahead. And even if you can't make #MDSCongress, October 5-9, 2018, get your highlights and Editor's Picks here.
Parkinson disease articles published in 2018 reveal deeper dives into factors that include the impact of sleep and fatigue on symptoms.
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
New studies shed light on topics such as nonencephalic pain and headache chronicity; benign childhood epilepsy with centrotemporal spikes and social cognition; and causal triggers of Alzheimer disease onset.